Atlas Trials

A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCEPT Blood System for Platelets With LED Illuminator.

Clinical trial NCT06697223 · COMPLETED

Trial details

NCT number
NCT06697223
Sponsor
Cerus Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2025-01-23
Primary completion
2025-06-02
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.